// App-Quantinova.ai

: Disease Characterization and Response Prediction in Myeloma Patients Undergoing Conventional and Cellular Therapies from Circulating Tumor DNA

Researchers

Presenter

  • Hitomi Hosoya

Principal Investigators

  • Mia Carleton

  • Kailee L Tanaka

  • Brian Sworder

  • Vanna Hovanky

  • George E Duran

  • Tian Y. Zhang

  • Michael S. Khodadoust

  • David B. Miklos

  • Sally Arai

  • David Iberri

  • Michaela Liedtke

  • Surbhi Sidana

  • David M. Kurtz

Medical Centers

  • Division of Hematology, Department of Medicine, Stanford University Medical Center, Stanford, CA

  • Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA

  • Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA

  • Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University Medical Center, Stanford, CA

  • Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved